期刊文献+

参苓白术散合葛根芩连汤治疗溃疡性结肠炎30例 被引量:2

Shenling Baizhu Powder Combined with Gegen Qinlian Decoction in Treating Ulcerative Colitis for 30 Cases
下载PDF
导出
摘要 目的探讨参苓白术散合葛根芩连汤加减治疗慢性溃疡性结肠炎的临床疗效。方法60例慢性溃疡性结肠炎患者被随机分为治疗组和对照组各30例,分别给予口服参苓白术散合葛根芩连汤加减的中药煎剂和柳氮磺砒啶肠溶片,疗程均为3个月。观察2组用药后临床疗效。结果治疗组总有效率达90%(27/30),明显高于对照组的80%(24/30)。结论参苓白术散合葛根芩连汤加减对慢性溃疡性结肠炎有显著的临床疗效。 Objective To observe the efficacy of Shenling Baizhu powder and Gegen Qinlian decoction in the treatment of ulcerative colitis(UC).Methods Sixty patients with chronic ulcerative colitis were randomly divided into the treatment group(30 cases)which was treated with Shenling Baizhu powder and Gegen Qinlian decoction and control group(30 cases)which were applied with sulfasalazine enteric-coated tablets.The treatment course of each group was 3 months.The clinical efficacy of the two groups was observed.Results The total effective rate in the treatment group was 90%(27/30),significantly higher than that in the control group(80%,24/30).Conclusion Shenling Baizhu powder and Gegen Qinlian decoction has significant clinical efficacy on UC.
作者 张玉 高宏平 郑娇 孙杭 ZHANG Yu;GAO Hongping;ZHENG Jiao;SUN Hang(Department of Proctology,Xuzhou First People's Hospital,Jiangsu Province,Xuzhou 221002,China)
出处 《中国中医药现代远程教育》 2022年第2期84-86,共3页 Chinese Medicine Modern Distance Education of China
关键词 慢性溃疡性结肠炎 参苓白术散 葛根芩连汤 中西医结合疗法 经方 ulcerative colitis Shenling Baizhu powder Gegen Qinlian decoction therapy of traditional Chinese medicine classical prescription
  • 相关文献

参考文献6

二级参考文献94

  • 1柳婧,高翔,陈烨,梅俏,朱良如,韩英,田丰,张虎,张晓岚,缪应雷,于晓峰,施华秀,王承党,刘玉兰,王晓艳,李学锋,钱家鸣,胡品津,曹倩.中国炎症性肠病患者深静脉血栓情况调查:一项全国多中心回顾性研究[J].中华炎性肠病杂志(中英文),2017,1(1):24-28. 被引量:26
  • 2陈白莉,钱家鸣,吴开春,盛剑秋,许建明,冉志华,袁耀宗,王化虹,陈志芬,李兆申,唐承薇,侯晓华,侯妍妍,陈旻湖,胡品津.英夫利西治疗活动性溃疡性结肠炎疗效与安全性的临床研究[J].中华炎性肠病杂志(中英文),2017,1(1):20-23. 被引量:15
  • 3Alicja Wiercinska-Drapalo,Flobert Flisiak,Jerzy Jaroszewicz,Danuta Prokopowicz.Plasma interleukin-18 reflects severity of ulcerative colitis[J].World Journal of Gastroenterology,2005,11(4):605-608. 被引量:16
  • 4李亚红,韩英,吴开春.炎症性肠病危险因素的流行病学调查研究[J].胃肠病学和肝病学杂志,2006,15(2):161-162. 被引量:19
  • 5Mills K H. Regulatory T cells: friend or foe in immunology to infection[J]. Nat Rev Immunol, 2004, 4(11) : 841-855.
  • 6Kelsen J, Hvas C L, Agnholt J, et al. CD4^+CD25^+regula- tory T cells and their importance to human illnesses[ J]. Ugeskr Laeger, 2006, 168(1) : 32-37.
  • 7Liu H, Uu B, Xu D, et al. CD4^+ CD25^+ regulatory T ceils cure murine colitis: the role of IL-10, TGFbeta, and CTLA4 [J]. J Immunol, 2003, 171(10): 5012-5017.
  • 8Maloy K J, Powrie F. Regulatory T ceils in the control of im- mune pathology[J], NatImmunol, 2001, 2(9) : 816-822.
  • 9Duque J, Diaz-Munoz M D, Fresno M, et al. Up-regulation of cyclooxygenase-2 by interleukin-1 beta in colon carcinoma cells[J]. Cell Signal, 2006, 18(8): 1262-1269.
  • 10Yu Q T, Saruta M, Avanesyan A, et al. Expression and functional characterization of Foxp3^+ CD4^+ regulatory T cells in ulcerative colitis [ J ]. Inflamm Bowel Dis, 2007, 13 ( 2 ) : 191-199.

共引文献785

同被引文献41

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部